Skip to content
Screener

Medifast MED Q2 2026 earnings

Reported August 3, 2026 · After market close

Revenue$76.4MBeat by $3.7M
EPS-$0.28Beat by $0.37
Revenue estimate$72.7M
EPS estimate-$0.65
“In the second quarter, we continued to see signs of a turnaround in our business. Revenue remained sequentially stable, supported by steady growth in coach productivity and positive coach leadership trends. Combined with the energy and engagement demonstrated at our recent National Coach Convention, these leading indicators have historically been precursors of future growth.”
Cash Equivalents

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$71.3M
EPS estimate-$0.35

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$134.06M-15.1%
Enterprise value$78.63M+13.6%
P/S0.4×+0.1×

FAQ

When did Medifast report Q2 2026 earnings?
Medifast (MED) reported Q2 2026 earnings on August 3, 2026 after market close.
What were Medifast's Q2 2026 revenue and EPS?
Medifast reported revenue of $76.4M and eps of $-0.28 for Q2 2026.
Did Medifast beat estimates in Q2 2026?
Revenue beat the consensus estimate of $72.7M by $3.7M. EPS beat the consensus estimate of $-0.65 by $0.37.
How did Medifast's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 27.6% from $105.6M a year earlier.
Where can I find Medifast's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-051845) and the 10-Q periodic report (0001628280-26-051928) directly on SEC EDGAR. The filing index links above go to sec.gov.